Results: Of 120 patients, 109 were diagnosed with papillary thyroid carcinoma (90.8%) and 11 had follicular thyroid carcinoma (9.2%). The average age was 50 years, and 90 patients (75.0%) were female. There were 48 patients diagnosed with central lymph node metastasis based on pathology reports after lymph node dissection (40.0%). Univariate analysis showed that lymphovascular invasion (P < .001), extrathyroidal extension (P < .001), and multilobe involvement (P = .02) were significantly associated with central lymph node metastasis. Multivariable logistic regression showed that decreasing age (P < .001) and extrathyroidal extension (P < .001) were independent predictors of central lymph node involvement.
Conclusions: Patients with evidence of lymphovascular invasion, extrathyroidal extension, and tumor involvement of multiple lobes were more likely to have central lymph node metastases. Increasing age correlated with reduced risk of central nodal involvement. These features may be used to determine the need for prophylactic central lymph node dissection in patients diagnosed with differentiated thyroid cancer.
comparison of Genomic classifier Testing in Indeterminate Thyroid Nodules
Jonathan C. Simmonds (Presenter); Rebecca A. Compton, MD; Jagdish K. Dhingra, MBBS, FRCS Objectives: This study compares the performance of new Afirma Genomic Sequencing Classifier (GSC) testing (Veracyte) with the first-generation Afirma Gene Expression Classifier (GEC) testing (Veracyte) in cytologically indeterminate thyroid nodules within a large community-based practice.
Methods: A retrospective review of all patients who underwent ultrasound guided fine-needle aspiration (FNA) biopsy of a thyroid nodule was performed by a single otolaryngologist at a large community-based practice in Brockton, Massachusetts, between 2013 and 2017 . Patients with cytologically indeterminate pathology (Bethesda grade III or IV) who underwent GEC or GSC testing were analyzed.
Results: A total of 1451 thyroid FNA biopsies were performed, of which 206 (14.2%) were found to have indeterminate (Bethesda III or IV) cytopathology. GEC testing was performed in 149 (72.3%) cases. In these patients, 40 (26.8%) were found to be benign, 102 (68.5%) were suspicious, and 7 (4.7%) had no results. Surgical excision (total thyroidectomy or lobectomy) was performed in 56 of the 102 patients with suspicious GEC testing, with final pathology showing malignancy in 25 (45%) of those patients. GSC was performed in 57 (27.7%) cases, of which 33 (57.9%) were found to be benign, 21 (36.8%) were suspicious, and 3 (5.3%) had no result. Surgical excision was performed in 12 of the 21 patients with suspicious GSC testing, with final pathology showing malignancy in 3 (25%) of patients.
Conclusions: Our results show that in a community-based practice, Afirma GSC testing appears to improve the ability to avoid surgical intervention in patients with thyroid nodules that have indeterminate cytopathology as compared with the Afirma GEC testing.
complications following Pituitary Surgery: Birmingham university Experience
Ahmed Youssef, MD, PhD (Presenter); Shahzada Ahmed, DLO, MBChB, FRCS; Amr Kholeif, MD; Kymistry Best
Objectives: Pituitary surgery is performed by many ear, nose, and throat/skull base units nowadays, in collaboration with neurosurgeons. Although many surgeons are focused on techniques and avoidance of major intraoperative incidents such as bleeding, there is a list of complications that could happen during or immediately following surgery or on a longterm basis for those patients.
Methods: We studied the complications that we encountered over the past 3 years, including metabolic, vascular, and neurologic complications, cerebrospinal fluid (CSF) leaks, and quality of life following pituitary surgeries. We included about 150 patients in this study.
Results: Metabolic complications and CSF leakage are at the top of lists of complications. Making a protocol to deal with endocrine complications and having a good knowledge of this is a crucial issue for any pituitary/skull-based surgeon. We listed other complications and illustrated the rationale and management of an example of each category.
Conclusions: Pituitary surgery has become an integral step in the career of many skull-based surgeons. Knowledge of the complications following the procedure is as important as the technical steps of the surgery.
conservative Management for Two cases of Thyroglossal duct cyst carcinoma Sara Sun (Presenter); Daniel Robertson, MD; Prerna Kumar, MD; James A. Geraghty, MD Objectives: Thyroglossal duct cyst (TGDC) carcinomas occur in about 1% of diagnosed TGDCs. Histologically, most are consistent with papillary thyroid carcinoma (PTC). The management of TGDC carcinomas after the Sistrunk procedure remains controversial. Attendees will (1) review the current knowledge on the limits of accepted application of conservative management for TGDC carcinomas and (2) examine their own approach to managing the cases described here.
Methods: This is a report of 2 cases of TGDC carcinoma with literature review.
Results: Patient 1 is a 22-year-old woman with a 0.7-cm mass consistent with TGDC carcinoma of PTC subtype with negative margins. Patient 2 is an 18-year-old woman with TGDC adherent to surrounding structures intraoperatively. Pathology showed a 1.5-cm mass consistent with PTC, with soft tissue and hyoid bone involvement. However, following tumor board review, the mass was determined to be low risk.
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Both patients had normal thyroid studies and no abnormal lymph nodes on imaging. Conservative management with surveillance was recommended for both. Total thyroidectomy and radioactive iodine were not performed.
Conclusions: We report 2 cases of TGDC carcinoma with varying features. The literature suggests conservative management for low-risk features, including age younger than 45 years, size less than 2 cm, no invasion of local structures, no thyroid abnormalities, and no lymph node involvement. Despite this, the qualification of invasive features is ambiguous and the inflammatory nature of TGDCs can produce local scarring that may be clinically difficult to distinguish from true invasion. Both patients presented here were treated conservatively. Given the excellent outcomes for TGDC carcinomas, we support a less-invasive management approach. Objectives: Neck scarring following thyroid/parathyroid surgery can negatively affect quality of life. The transoral endoscopic approach (TOEA) to the central neck eliminates this morbidity. It has been demonstrated to be safe and effective in performing thyroidectomy, parathyroidectomy, and central neck dissection. Given the primary benefit of the technique is cosmetic, there is a need for an objective study comparing cosmetic outcomes between the transcervical approach (TCA) and TOEA. Here we present such a study.
Methods: Standardized photographs of postoperative thyroidectomy and parathyroidectomy patients completed via TCA and TOEA were reviewed. Images were scored in a blinded fashion by 4 head and neck endocrine surgeons using the validated Scar Cosmesis Assessment and Rating (SCAR) Scale. SCAR scores between techniques were compared using a linear regression model accounting for intrarater correlation in scoring. Interrater reliability (IRR) was determined using an intraclass correlation coefficient (ICC) with a 2-way mixed-effects model.
Results: A total of 48 patients were included for analysis, with 30 (63%) and 18 (37%) in the TCA and TOEA cohorts, respectively. The mean age was 48.8 ± 15.1 years, and the median postoperative follow-up time was 3 weeks (range, 1-34 weeks Methods: A retrospective cohort study was conducted, using the NSQIP database, of adults who underwent total thyroidectomy, subtotal thyroidectomy, and completion thyroidectomy between 2016 and 2017. The primary outcome variable was operative time. The secondary outcome variable was postoperative hematoma rates. The exposure variable was use of alternative sources of cautery. A multivariable analysis was performed to control for the confounding variables age, sex, body mass index, race, history of bleeding disorder, hypertension requiring medication, preoperative platelet count, preoperative international normalized ratio, American Society of Anesthesiologists classification, and drain use.
Results: A total of 5307 cases were analyzed; 1666 used conventional cautery and 3641 used alternative sources. Use of alternative sources of cautery added 7.15 minutes to the operative time (95% confidence interval [CI]: 2.84-11.46), which was statistically significant (P = .0011). There was no statistically significant difference in postoperative hematoma rates when conventional cautery was compared with alternative sources (odds ratio: 0.6817; 95% CI: 0.40-1.17; P = .1621).
Conclusions: Use of alternative sources of cautery prolongs operative time and does not affect postoperative hematoma rates for thyroidectomy. Surgeons may consider using conventional sources of cautery as a cost-effective strategy to increase surgical efficiency and decrease anesthetic time for patients. Objectives: Primary hyperparathyroidism (PHPT) causes systemic calcium disturbances through targeting organs that depend on calcium for normal structure and function. We examined whether inner ear structures, such as the otoconia in the saccule and utricle, which are composed of calcium carbonate deposited on a protein framework, may also be affected by PHPT.
Methods: Subjects were patients with PHPT and controls with no otologic history. All patients were recruited from the University of Connecticut Health's otolaryngology clinic from June to November 2018. PHPT was diagnosed based on a history of hypercalcemia, elevated parathyroid hormone (PTH) level, and successful response to parathyroidectomy.
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The enzyme-linked immunosorbent assay method was used to measure serum levels of otolin-1, a framework protein of otoconia, which we have proposed as an inner ear biomarker (Parham et al., Oto-HNS. 2014; 151[6]:1038 -1040 Parham et al., Otol Neurotol. 2018; 39(4):e269-e273) .
Results: Mean otolin-1 (±standard error of the mean) levels were 132.9 ± 27.7 and 94.12 ± 24.1 pg/mL in the control (n = 16) and PHPT (n = 7) subjects, respectively. This difference was not statistically significant (P = .39). However, there existed a very strong positive correlation between PTH and otolin-1 levels in the PHPT group (r 2 = 0.85). A correlation between otolin-1 and ionized or total calcium was not found.
Conclusions: Our preliminary results support the hypothesis that PHTP may affect the inner ear structure. Based on these results, we predict increased prevalence of otolithic vestibular disorders in PHTP patients. Objectives: To analyze whether insurance differences affect disease presentation and surgical outcomes of parathyroidectomy patients.
Effect of Health Insurance on disease Presentation of Parathyroidectomy Patients
Methods: This retrospective cohort study evaluated all patients (n = 100) who underwent parathyroidectomies for primary hyperparathyroidism from January 2016 and December 2017 at 2 hospitals affiliated with a single academic institution. Socioeconomic characteristics, medical history, surgical characteristics, and postoperative outcomes were collected. Main outcome measures were preoperative and postoperative adenoma size, the presence of preoperative symptoms, and the incidence of postoperative complications, including dysphonia.
Results: Most patients held private insurance (55%), while the remainder held primarily public insurance or were uninsured. Although patients with public insurance had significantly larger adenomas on preoperative imaging (17.8 vs 12.4 mm, P = .004), there were no significant preoperative differences in terms of symptoms (P = .683), parathyroid hormone (PTH) level (P = .127), or calcium levels (P = .443). Patients with public insurance had greater average adenoma mass (2180 vs 1718 mg, P = .573) and higher postoperative PTH than those with private insurance (62.6 vs 49.9, P = .306). Despite this, there were no differences in the incidence of postoperative complications (P = .398), regardless of insurance status.
Conclusions: Type of health insurance may be associated with differences in initial presentation, which warrants further investigation.
Effect of Proton Pump Inhibitors on Symptomatic Hypocalcemia after Thyroidectomy
Vanessa Trieu (Presenter); Daniel I. Gerges, MD; Nathan C. Grohmann, MD; Mirabelle B. Sajisevi, MD Objectives: To compare the incidence and duration of postoperative symptomatic hypocalcemia between those taking and those not taking proton pump inhibitors (PPIs) at the time of total or completion thyroidectomy.
Methods: A retrospective chart review of adult patients who underwent total or completion thyroidectomy at a tertiary medical center from January 2013 to January 2018 was performed. Patients with known parathyroid disease, end-stage renal disease, and prior gastric bypass surgery were excluded. Patients who developed permanent hypoparathyroidism were also excluded. Rates and duration of symptomatic hypocalcemia and usage of PPIs were recorded.
Results: We identified 408 patients, 37 of whom met exclusion criteria, resulting in a total of 371 patients. Fifty-nine of 371 (15.9%) patients developed symptomatic hypocalcemia. The average duration of symptoms was 4.3 days (standard deviation [SD] 3.77 days). Eighty-nine of 371 (24.0%) were on a PPI at the time of surgery. Of those, 16 (17.9%) developed symptomatic hypocalcemia. Of the 282 patients not on a PPI, 43 (15.3%) developed symptomatic hypocalcemia (P = .618). The average duration of symptoms for patients on a PPI was 4.8 days (SD 2.8 days) and 4.2 days (SD 4.1 days) for those not taking PPI.
Conclusions: There was no significant difference in incidence or duration of symptomatic hypocalcemia after total or completion thyroidectomy between patients who were and were not taking PPIs at the time of surgery. Therefore, patients may continue their PPI at the time of surgery without increased risk of symptomatic hypocalcemia.
Feasibility and Safety of Transoral Robotic
Thyroidectomy using daVinci SP Young Min Park (Presenter); Eun-Chang Choi, MD, PhD; Da-Hee Kim, MD; Min Seok Kang, MD; So-Yoon Lee, MD; Yoon Woo Koh Objectives: Transoral thyroid surgery is an ideal method for minimally invasive thyroidectomy because there is less flap dissection during the procedure and no postoperative scars. Nonetheless, technical obstacles have precluded the wide dissemination of this procedure. We present the surgical procedures and outcomes of transoral robotic thyroidectomy (TORT) without CO 2 gas insufflation using the daVinci SP system. Methods: From October 2018 to January 2019, we performed 4 cases of TORT without gas insufflation at Yonsei University Hospital. We used a 2.5 cm intraoral port for the system's 4 robotic arms. The working space was maintained with a selfretaining retractor that was designed for the transoral port. The surgical outcomes were retrospectively reviewed.
Results: Four patients (mean age 35.2 ± 7.6 years; mean tumor size 1.5 ± 0.9 cm) underwent unilateral thyroid lobectomies. Three patients had papillary thyroid carcinomas and 1 had benign nodules. The mean surgical time was 312 ± 31 minutes; the mean hospital stay was 4.1 ± 0.5 days. There were no reports of transient or permanent vocal cord palsy, recurrence, or mortality during the median follow-up period Poster Presentations P163 ENdOcRINE of 5.1 months. Transient paresthesia of the lower lip and the chin was observed in 3 of 4 patients with no permanent injury of the mental nerve.
Conclusions: TORT using the daVinci SP system is feasible and safe for selected patients and can be a potential alternative approach for scarless and less-invasive remote access thyroid surgery together with technical refinement.
From Sistrunk to the Robot: Surgical Technique for Thyroglossal duct cyst Courtney B. Shires, MD (Presenter); Mihir R. Patel, MD; Merry E. Sebelik, MD Objectives: Since Dr Sistrunk published his series of hyoid bone excision for thyroglossal duct (TGD) cyst in 1919, straightforward transcervical excision has had a high rate of success. However, for those TGD cysts that extend into the tongue base, or failed prior excision, exposure can be challenging. The aim of this study is to analyze the outcomes of a case series of patients who underwent combined transcervical and transoral robotic surgery (TORS) to completely excise large or recurrent TGD cysts.
Methods: Retrospective chart review of a case series of 5 adult patients who underwent a combined Sistrunk and TORS approach to treat large or recurrent TGD cysts at a single tertiary care institution.
Results: Of the 5 patients, 3 had undergone excision in the past, with cyst recurrence deep to the hyoid bone and extending into the tongue base intrinsic musculature. Two had not had prior surgery, but the cyst was primarily within the tongue base, one massively so. All patients underwent combined excision, with the TORS component completed first before the transcervical exposure. All patients required pharyngotomy by the nature and location of the TGD cyst, and all underwent primary closure through the neck incision. All healed well, resumed oral intake, and have demonstrated no recurrence in short-term follow-up.
Conclusions: A combined transcervical and transoral approach is feasible and successful in treating the adult patient with large or recurrent TGD cyst.
Hyperparathyroid disease with chronic Renal Failure
Malhar Parikh (Presenter); D'Antoni C. Dennis, MD; Jacques C. Peltier, MD Objectives: To discuss the management of a rare case of triple parathyroid adenoma.
Methods: Both triple parathyroid adenomas and parathyroid carcinomas are exceedingly rare. Herein we report a unique case in which a triple parathyroid adenoma presents as a parathyroid carcinoma in a patient with chronic renal disease.
Results: J.Y. is a 60-year-old man who presented with bone pain, psychiatric overtones, hematuria, and dysuria. Work-up showed calcium of 13 mg per dL, parathyroid hormone (PTH) level of 1789 pg per mL, and glomerular filtration rate (GFR) of 25 mL per minute. Computed tomography scan showed a left inferior parathyroid lesion and sestamibi scan localized to the same area. We performed a left inferior parathyroidectomy, left thyroid lobectomy, and central neck dissection because of concern for parathyroid carcinoma. Postoperatively, PTH dropped to 51 pg per mL. Pathology revealed a left inferior parathyroid adenoma with an incidental follicular variant encapsulated papillary thyroid cancer. Six weeks postoperatively, PTH began to increase and peaked at greater than 900 pg per mL. Repeat sestamibi scan was negative. Venous sampling showed increased PTH levels in the right inferior parathyroid area. We performed a right inferior and superior parathyroidectomy with completion thyroidectomy. Pathology was negative for malignancy, and revealed a right superior and right inferior benign hyperplastic parathyroid adenoma.
Conclusions: In a patient with primary hyperthyroidism with PTH well above the upper the limit of normal and chronic kidney disease, multiple adenomas as well as parathyroid carcinoma should be considered, as they both have similar presentations and incidence.
Intraoperative Loss of Signal in Thyroid cancer Surgery
Manish Shaha, MD (Presenter); Brent A. Chang, MD; Ashok R. Shaha, MD
With the rapidly rising incidence of thyroid cancer in the United States, more than 150,000 thyroidectomies are performed annually. Loss of signal during surgery for differentiated thyroid cancer remains a controversial subject because some surgeons would opt to perform completion thyroidectomy concurrently after the dominant lobectomy is performed, whereas others may stage the procedure to avoid bilateral vocal cord palsy, possibly leading to tracheostomy. The responsibility of a surgeon is to protect the nerve. Neuromonitoring has become a mainstay of thyroid surgery. Most of the time, loss of signal is due to traction or thermal injury. Once signal loss on the ipsilateral side occurs, it is difficult for the surgeon to go on the contralateral side for completion thyroidectomy even if it is strongly indicated. Usually, the surgical procedure is aborted, and the completion is performed after several months, at which time most of the function is regained. The clinical implication of the loss of signal means nerve injury in the form of loss of nerve transmission. The reported incidence is approximately 8% to 11% at major institutions. There may be some surgeons who feel comfortable performing completion thyroidectomy at the same time if anatomically the nerve is intact. However, there is always a concern in such a situation for injury to the contralateral side. The nerve monitor is obviously a great tool, but technical dysfunction may occur due to instrumentation or dislodgement of the endotracheal tube. Thus, the operative surgeon must be familiar with troubleshooting when dealing with the problem of signal loss. The authors will describe the literature pertaining to loss of signal in planned thyroidectomy for differentiated thyroid cancer. Objectives: Recurrent laryngeal nerve (RLN) injury is a well-known complication of parathyroid surgery. Despite ample data, there is still uncertainty about the role of intraoperative monitoring (IONM) in mitigating RLN damage. This study is the first, to our knowledge, to investigate the effects of IONM in patients with secondary or tertiary hyperparathyroidism undergoing total, subtotal, or completion parathyroidectomy and is a retrospective review.
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Methods: We included all patients presenting for total, subtotal, or completion parathyroidectomy at a tertiary referral hospital from 2013 to 2018. Information about demographics, previous neck surgery, perioperative data, pathology, and possible RLN injury was collected. Two groups were formed for analysis: IONM vs nonmonitored (NM).
Results: A total of 105 patients underwent 107 surgeries with IONM used in 71 cases. The groups were similar in demographics but significantly differed (all P < .05) in preincision parathyroid hormone level (IONM = 2091.44 vs NM = 1334.87), surgery type (IONM = 62.9% vs NM = 27.8% subtotal), and surgery length in minutes (IONM = 155.21 vs NM = 182.22). We observed 6 cases (6/71; 8.45%) of persistent RLN complaints (3 or more weeks postoperatively) and 4 cases (4/71; 5.63%) of temporary complaints with the use of IONM compared with only 1 temporary complaint (1/36; 2.78%) in NM procedures (P = .129).
Conclusions: These results suggest that the use of IONM does not provide a protective effect on the RLN in patients with secondary or tertiary hyperparathyroidism undergoing total, subtotal, or completion parathyroidectomy. Prospective, randomized studies are needed to explore the use of IONM in this patient population
Misdiagnosed Aggressive Functional Thyroid carcinoma: A case Report April Peterson (Presenter); Daniel S. Brickman, MD
Objectives: We present a misdiagnosed case thought to be toxic multinodular goiter but having short interval recurrence and metastatic disease. We conducted a literature review of functional thyroid malignancies.
Methods: A 68-year-old woman with a history of hyperthyroidism was treated medically for Graves' disease. After failure to improve, she underwent thyroidectomy, showing poorly differentiated carcinoma in a background of PTC with positive margins, extensive angioinvasion, and extrathyroidal extension. I-131 treatment was given, and a whole-body scan showed central neck and lung uptake. She re-presented 1 year later with hoarseness, a neck mass, and NA confirmed recurrence. Despite discontinuing levothyroxine, her thyroid-stimulating hormone (TSH) level remained suppressed (TSH <0.03, free T4 1.07, thyroglobulin 45,840 without antibodies, thyroid-stimulating immunoglobulin +1.38%), and she required medical suppression. Whole-body imaging showed a hypermetabolic neck mass, adenopathy, lung nodules, and osseous/liver metastasis. She received palliative radiation to her metastatic disease and recently started tyrosine kinase inhibitor therapy.
Results: Rates of thyroid cancer in hyperthyroid patients are low. Most of these are papillary thyroid carcinomas followed by follicular and Hurthle cell carcinomas. Hyperthyroidism following thyroidectomy is rare and usually occurs with bulky metastatic disease from follicular thyroid carcinomas. Reported mechanisms include autonomous production of thyroid hormone, formation of TSH receptor antibodies, and expression of 5′-iodothyronine deiodinase increasing the conversion of T3.
Conclusions: Clinicians should remain aware of the possibility of malignancy with hyperthyroidism. In patients who remain euthyroid/hyperthyroid following thyroidectomy, metastatic disease from a thyroid carcinoma should be a suspicion. Results: A total of 11,294 patients were identified. Of these, 8392 (74.3%) were female and 2902 (25.7%) were male. Ages ranged from 18 to 90 years. A total of 8959 (79.3%) patients had operations performed by GS and 2335 (20.7%) performed by OTO. Of the analyzed data, length of stay (LOS; P = 2.83E-06) was the only statistically significant postoperative difference. Median LOS was 0 days for OTO and 1 day for GS. Total operation time (P = 5.53E-10) and estimated probability of morbidity (P = 6.85E-15) were significantly higher in patients whose procedure was performed by OTO. The median operative time was 87 minutes for OTO and 79 minutes for GS. Venous catheterization for selective organ blood sampling was performed more often by GS (P = 2.2E-16). ACS estimate of probability of morbidity was 0.014 for OTO and 0.013 for GS. There were no significant differences between preoperative lab values or general postoperative complications between the groups.
Parathyroidectomy Outcomes for Otolaryngologists versus General Surgeons
Conclusions: There is minimal difference between OTO and GS PT outcomes, although LOS is shorter for OTO patients, despite higher preoperative morbidity.
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Prevalence and Aggressiveness of Papillary Thyroid cancer in Graves' disease Eunice Linh You (Presenter); Marco A. Mascarella, MD; Richard J. Payne, MD, FRCS Objectives: The prevalence and aggressiveness of thyroid cancer in Graves' disease (GD) patients varies widely between studies. The aim of this study was to evaluate the prevalence of papillary thyroid carcinoma (PTC), including aggressive forms, and to elucidate patient-and tumor-associated factors that may predict aggressiveness in GD patients.
Methods: We performed a retrospective chart review of a cohort of GD patients undergoing thyroidectomy for medically refractory disease from 2006 to 2018. Clinicodemographic factors, extension of disease intraoperatively, as well as postoperative histopathology were collected and assessed. Aggressive PTC was defined as patients with lymph node metastasis, aggressive histologic variants, and/or extrathyroidal extension.
Results: A total of 66 patients were included in the study, with a mean age of 46 (±14) years. Fifty-five percent (36/66) of patients had PTC, of which half (18/36) were papillary thyroid microcarcinoma and 25% (9/36) had aggressive pathologic features. In the aggressive PTC group, lymph node metastasis to the central compartment was present in 7 of 9 cases, extrathyroidal extension in 3 cases, and 2 patients had a Hurthle cell variant tumor.
Conclusions: In this study, more than half of patients with GD undergoing thyroidectomy had a concurrent thyroid malignancy, with 25% of these malignancies having aggressive features.
Quality Indicators of central compartment Neck dissection in Thyroid Surgery
Alexandra Quimby, MD (Presenter); Martin Corsten, MD, FRCSC; Stephanie E. Johnson-Obaseki, MD Objectives: To assess quality indicators for central compartment neck dissection (CCND) performed for thyroid cancer. Specific quality indicators used were number of lymph nodes removed and rates of hypocalcemia.
Methods: A retrospective cohort study was performed using the American College of Surgeons National Quality Improvement Program. We included all patients receiving total thyroidectomy for thyroid disease, with and without central compartment lymph node dissection (CCLND). Patients who had undergone concomitant lateral compartment nodal dissection were excluded. The number of lymph nodes resected was analyzed as a continuous variable. Multivariable logistic regression analysis was then used to assess for an association between CCLND and hypocalcemia and whether the number of lymph nodes removed influenced hypocalcemia rates.
Results: A total of 6108 patients met the inclusion criteria: 1565 with CCLND and 4543 without. The median number of lymph nodes removed in patients who had undergone CCLND was 2 (interquartile range 0-7). Multivariable logistic regression analysis was used to assess for an association between CCLND and hypocalcemia and did not demonstrate a statistically significant association between postoperative hypocalcemia and CCNLD, regardless of the number of lymph nodes resected.
Conclusions: Surgical quality indicators are increasingly important for measurement of patient outcomes. The number of lymph nodes resected during CCLND has been described as a prognostic factor for thyroid cancer. These data demonstrate that CCLND is reported in many cases in which very few lymph nodes are removed. Our data did not demonstrate an association between CCLND and hypocalcemia rates. Methods: A systematic review of the literature and metaanalysis of published data were conducted using articles indexed on the PubMed and Scopus databases. Englishlanguage articles were included if they reported operative times and complications for retroauricular thyroid surgery. A meta-analysis of proportions was then performed for nominal variables, and weighted averages and standard deviations were calculated for continuous variables.
Results: Twelve articles were included in the meta-analysis. Average unilateral thyroid surgery operative times for robotic and endoscopic approaches were 126.3 ± 41.6 (n = 271) and 120.5 ± 34.3 minutes (n = 215), respectively (P > .05). The operative time for all approaches was 123.65 ± 38.72 minutes (n = 476). The rate of temporary recurrent laryngeal nerve palsy was 6.54% (95% confidence interval: 3.55-10.35). Permanent palsy occurred only in the setting of gross tumor invasion requiring resection. The average tumor size was 1.29 ± 0.99 cm. The average postoperative drainage output was 137.93 ± 67.29 mL. The average length of stay was 4.09 ± 1.13 days.
Conclusions: Published data suggest that retroauricular thyroid surgery with appropriate patient selection is a safe alternative to open surgery. Continuous evolution of thyroid surgery approaches may cause this technique to fall out of favor. 
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Results: Of 58,312 patients who met inclusion criteria, median LOS was 1 day (range, 0-368 days). Of all cases, 14.4% were discharged on POD 2 or greater (n = 8406). Significant predictors of prolonged LOS included female sex (odds ratio [OR]: 1.45; 95% confidence interval [CI]: 1.28-1.64), black race (OR: 1.43; 95% CI: 1.27-1.60), race other than black and white (OR: 1.86; 95% CI: 1.55-2.24), increased operation time (OR: 1.59; 95% CI: 1.53-1.66), history of congestive heart failure (OR: 4.00; 95% CI: 2.04-7.87), and chronic dyspnea (OR: 1.49; 95% CI: 1.30-1.70). Patients who had prolonged LOS had higher rates of unplanned readmission (3.0% vs 1.7%, P < .001), reoperation rates (3.6% vs 0.4%, P < .001), and rates of postdischarge complications (3.3% vs 0.7%, P < .001).
Conclusions: This study identified patient and surgical risk factors that were associated with increased LOS following total thyroidectomy. These risk factors can be used to identify those patients at risk for prolonged hospital stays and guide preoperative and postoperative planning.
Transoral Endoscopic Thyroidectomy and Parathyroidectomy: First Series in Israel
Niddal Assadi (Presenter); Eran E. Alon, MD; Avi Khafif Hefetz Objectives: The transcervical approach has been the primary route of access for the thyroid and parathyroid gland since its description by Kocher 140 years ago. Several approaches have been suggested for minimizing the surgical scar, but none of them have become common practice. Thus, a role for a new novel technique still exists for improving surgical esthetic outcome. The transoral endoscopic transvestibular approach (TOETVA) has been recently reported as a novel approach for extraction of thyroid or parathyroid tumors. The aim of our study is to show the feasibility and safety of TOEVTA for thyroid and parathyroid surgery in Israel.
Methods: Case series of patients undergoing TOEVTA for thyroidectomy and parathyroidectomy at our institution. The study was approved by the institutional review board.
Results: Twenty-seven patients (15 thyroidectomies and 12 parathyroidectomies) underwent TOETVA and were included. Average time of surgery was 3.3 hours. One patient had transient vocal cord paralysis, and a second patient had altered chin sensation. A third patient had a seroma that resolved by aspiration and a skin laceration that was closed primarily with excellent healing. Surgery was successful in all patients, with no permanent complications.
Conclusions: We report the first series of patients in Israel undergoing TOETVA for thyroid and parathyroid tumors. The learning curve is steep but improving. Surgery was uneventful and safe. The results are comparable with previous reports. Objectives: Fine-needle aspiration (FNA) cytology is useful for diagnosis and management of thyroid nodules. However, false-negative rates for malignancy may occur and affect our success on treatment. In this retrospective study, we aim to investigate the reasons for false-negative results, such as tumor size.
Methods: Patients who had undergone total thyroidectomy or isthmolobectomy between 2011 and 2018 were retrospectively reviewed. A total of 400 cases were investigated. Patients who had final histopathologic diagnoses of thyroid carcinoma (papillary, follicular, medullary) were included. A total of 138 cases were eligible for the study.
Results: Of the 138 cases with final histopathologic diagnoses of thyroid carcinoma, 38 (27.5%) had an FNA biopsy (FNAB) report of benign (group A). Seventeen (12.3%) had follicular neoplasia/suspicious for follicular neoplasia (group B), 21 (15.2%) had atypia of undetermined significance/follicular lesion of undetermined significance (group C), 25 (18.1%) had an FNAB report of suspicious for malignancy (group D), and 37 (26.8%) had an FNAB report of malignancy. We also noted tumor size/nodule size and mean ratios were 0.5082 for group A, 0.5578 for group B, 0.7632 for group C, 0.8775 for group D, and 0.8291 for group E (analysis of variance, P < .001).
Conclusions: Tumor size might be more important than nodule size.
Two unprecedented complications of Thyroid Surgery
Ravi Sankar Manogaran, MS, DNB (Presenter); Arulalan Mathialagan; Amit Kumar Keshri; Mahalakshmi VNSSVAMS; Rajat Jain, MS; Pearly Pattayil Keerangat; Sabaretnam Mayilvaganan Objectives: To discuss 2 rare complications associated with thyroid surgery.
Methods: We reviewed prospectively maintained data of thyroidectomy cases in tertiary care centers from January 2018 to December 2018 and came across 2 rare but interesting complications.
Results: The first case is of a patient with papillary thyroid carcinoma (PTC) who underwent total thyroidectomy. In the immediate postoperative period, she developed stridor, and the possibility of bilateral recurrent laryngeal nerve (RLN) palsy was considered. Evaluation with FOL showed bilateral mobile vocal cords, whereas the subglottis showed extensive edema, and the patient had to be tracheostomized. After a short course of steroids, her airway became normal, her voice was as in the preoperative period, and she was decannulated. The second case is of a young woman who had completion thyroidectomy and central compartment lymph node dissection for PTC. She
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ENdOcRINE developed ptosis, myosis, and enophthalmos on postoperative day 1, without anhidrosis. A possible cause, in this case, could be trauma from retraction or injury to the communicating branch from RLN, as it was a reoperative case.
Conclusions: Thyroidectomy is not associated with complication in most cases, but the surgeon must be prepared to manage a few rare complications. A thorough patient preoperative work-up, complete knowledge of surgical anatomy, careful surgical dissection, and ability to understand, evaluate, and manage these rare complications are important in today's surgical practice.
unusual Thyroid Pathologies: SETTLEs, cASTLEs, and cEFTEs Jason F. Ohlstein, MD (Presenter); Mark E. Zafereo, MD; Randal S. Weber, MD; Diana Bell Objectives: Spindle epithelial tumor with thymus-like differentiation (SETTLE), carcinoma showing thymus-like differentiation (CASTLE), and carcinoma of the thyroid with Ewing family/PNET tumor elements (CEFTE) are very rare neoplasms of the thyroid gland. We report our experience with these malignancies.
Methods: Pathology and retrospective chart review of a single institution's experience with these rare neoplasms.
Results: We report 3 SETTLE, 3 CASTLE, and 3 CEFTE patients who presented to MDACC between 2012 and 2018. Eight patients had surgery, with 1 CASTLE patient receiving radiation alone. Six of the remaining 9 patients received adjuvant treatment. All patients are alive with stable disease or without recurrence. SETTLEs characteristically arise in a younger population, with pathology showing a highly cellular biphasic population of spindle cells in close association with epithelial cells and pan-keratin positivity. CASTLEs are characterized by a poorly differentiated basaloid cell population with positivity for CD5 and P40. CEFTEs will show a basaloid cell population and are defined by their EWSR1 gene rearrangement. Surgery followed by adjuvant radiation has been demonstrated to be effective for advanced disease and recurrence in both SETTLE and CASTLEs, while adjuvant chemotherapy has been an effective adjuvant treatment of CEFTEs.
Conclusions: SETTLE, CASTLE, and CEFTEs are extremely rare thyroid malignancies, with defining pathologic characteristics that are successfully managed with primary surgery, adjuvant treatment, and close surveillance. Methods: Retrospective case report of a single patient who underwent ECMO intraoperatively for management of severe airway stenosis due to a massive thyroid goiter with substernal extension.
Results: A 37-year-old man presented to a tertiary hospital with 1 day of acute dyspnea and was found to have a large (∼14 cm) mediastinal mass apparently arising from the thyroid, causing rightward tracheal deviation and significant compression of the distal trachea. Given concern that the patient could not be adequately ventilated through the distal tracheal obstruction, the decision was made to proceed with awake induction of V-V (venous-venous) ECMO. Bronchoscopy after intubation demonstrated severe stenosis of the distal trachea and left mainstem bronchus. During resection of the mass, there were multiple occasions during which complete airway obstruction occurred and no ventilation could be obtained through the endotracheal tube. After resection of the mass, ventilation improve significantly. At the conclusion of the procedure, the ECMO cannulas were removed. The patient was extubated on postoperative day 1 without complication and was discharged home on postoperative day 6. Final pathology showed a benign multinodular goiter.
Conclusions: ECMO can serve as a useful tool in the management of patients with critical airway stenosis in whom ventilation may not be possible with conventional methods. Objectives: This study seeks to determine if any demographic features, clinical risk factors, operative characteristics, or complications are associated with neck hematoma formation following thyroidectomy.
Methods: A retrospective study using the National Surgical Quality Improvement Program Thyroid database was conducted. The database identified patients who underwent thyroidectomies (n = 5791) in 2016, excluding those missing primary outcomes and those performed by specialties other than otolaryngology or general surgery.
Results: Of 5791 patients, 4525 women (78.1%) and 1266 men (21.9%), with a mean age of 51.7 (SD: 15.0) years who underwent thyroid surgery were included for analysis. Within the cohort, the most common procedure was total thyroidectomy (40.9%). This was followed by partial thyroidectomy (35.9%), thyroidectomy with neck dissection (radical or limited; 12.8%), revision of thyroid or cyst/adenoma removal (5.5%), and substernal thyroidectomy (4.8%). Overall, 1.6% of patients had a neck hematoma after surgery. Independent predictors of neck hematoma included female sex (odds ratio [OR] 
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FAcIAL thyroidectomy showed no difference in rates of neck hematoma (1.9% vs 1.2%; P = .40).
Conclusions: This study identified demographics, surgical characteristics, and postoperative complications associated with neck hematoma formation after thyroid surgery. This can be used to identify those at risk for this potentially lethal complication and guide postoperative care.
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